Cargando…
Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
Diffuse cutaneous systemic sclerosis (dcSSc) is associated with high mortality resulting from early internal-organ involvement. Clinicians therefore tend to focus on early diagnosis and treatment of potentially life-threatening cardiorespiratory and renal disease. However, the rapidly progressive pa...
Autores principales: | Herrick, Ariane L., Assassi, Shervin, Denton, Christopher P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922394/ https://www.ncbi.nlm.nih.gov/pubmed/35292731 http://dx.doi.org/10.1038/s41584-022-00765-9 |
Ejemplares similares
-
Clinical trial protocol: PRednisolone in early diffuse cutaneous
Systemic Sclerosis (PRedSS)
por: Herrick, Ariane L, et al.
Publicado: (2020) -
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis
por: Distler, Oliver, et al.
Publicado: (2018) -
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)
por: Griffiths-Jones, Deborah J, et al.
Publicado: (2023) -
Patient perception of disease burden in diffuse cutaneous systemic
sclerosis
por: Khanna, Dinesh, et al.
Publicado: (2019) -
The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)